ArticleBMC urology2022

Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients.

Ilknur Alsan Cetin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.